Tracy Rapp
Family · Memphis, TNNPI 1720451545
Payments from drug & device makers
Across 302 payments — averaging $21.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$679
- Gilead$630
- Lilly USA, LLC$578
- Merck$544
- Theratechnologies Inc.$396
- plus $2K from 22 others
What the payments were for
- Food & beverage$6,366100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 42 | $1,148 |
| AstraZeneca | 30 | $679 |
| Gilead | 31 | $630 |
| Lilly USA, LLC | 36 | $578 |
| Merck | 28 | $544 |
| Theratechnologies Inc. | 19 | $396 |
| Viiv Healthcare Company | 17 | $336 |
| Abbott | 10 | $303 |
| GSK | 16 | $296 |
| Bayer | 14 | $286 |
| AbbVie | 13 | $222 |
| Johnson & Johnson(2 entities) | 8 | $218 |
| Idorsia Pharmaceuticals US Inc | 10 | $178 |
| Astellas Pharma US Inc | 4 | $118 |
| Boehringer Ingelheim | 4 | $76 |
| Sanofi-aventis U.S. LLC | 4 | $59 |
| Hikma Pharmaceuticals USA | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Pfizer | 2 | $33 |
| Exact Sciences | 2 | $32 |
| Edwards Lifesciences | 1 | $31 |
| Myriad Genetic Laboratories, Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Dexcom, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,366 in reported general payments places this provider in the 90th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 95 | $103,843 |
| MounjaroTirzepatide | 27 | $35,224 |
| JardianceEmpagliflozin | 26 | $27,599 |
| EliquisApixaban | 20 | $24,137 |
| FarxigaDapagliflozin Propanediol | 22 | $23,806 |
| RybelsusSemaglutide | 24 | $23,239 |
| XareltoRivaroxaban | 15 | $19,038 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,136 |
| Dexlansoprazole DrDexlansoprazole | 12 | $3,008 |
| Famotidine | 110 | $2,055 |
| Fluticasone Propionate | 83 | $1,478 |
| Losartan Potassium | 122 | $1,357 |
| Atorvastatin Calcium | 166 | $1,357 |
| Methylprednisolone | 169 | $1,309 |
| Pantoprazole Sodium | 75 | $1,254 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,148 | $127,082119 claims |
| Lilly USA, LLCMounjaro | $578 | $35,22427 claims |
| Boehringer IngelheimJardiance | $76 | $27,59926 claims |
| PfizerEliquis | $33 | $24,13720 claims |
| AstraZenecaFarxiga | $679 | $23,80622 claims |
| Johnson & JohnsonXarelto | $218 | $19,03815 claims |
| GSKAnoro Ellipta | $296 | $5,13611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,706 family providers in Tennessee.
Other family in Memphis
- Marye BernardMemphis$128K
- Brett SnodgrassMemphis$47K
- John ScallionsMemphis$30K
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.